17 reports

  • MONOCLONAL ANTIBODIES TO INHIBIT ITGAM FOR CARDIOVASCULAR, IMMUNOLOGY AND KIDNEY DISEASES - DRUG PROFILE

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Autoimmune Disease
  • Pharmaceutical
  • Renal Disease
  • Type 2 Diabetes
  • ChemoCentryx, Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Renal Disease
  • United States
  • World
  • Product Initiative
  • ChemoCentryx, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018 (CONTD..2), H2 2018

PATIENTS WERE RANDOMIZED ##:##:## TO EMPA ## MG.

  • Diabetes
  • Renal Disease
  • United States
  • Company
  • Product Initiative

Patients will be randomized (##:##:##) to receive ## mg pacritinib twice daily (BID), ## mg pacritinib once daily (QD) or best available therapy.

  • Renal Disease
  • Therapy
  • United States
  • World
  • CTI BioPharma Corp.
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY BORYUNG PHARMACEUTICAL CO LTD, H1 2018
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY CELLMID LTD, H1 2018

The company offers products for the treatment of cancer; bone and joint diseases; renal diseases; immunology and infectious diseases and others.

  • Cell Therapy
  • Renal Disease
  • United States
  • Company
  • Product Initiative

Patients will be on up to two background therapies and will be randomized one-to-one to bardoxolone methyl or placebo.

  • Chronic Disease
  • Renal Disease
  • United States
  • Product Initiative
  • RPI
  • Stage of Development

Kadmon offers products in the therapeutic areas of oncology, infectious diseases, immunology, and neurodegenerative disease.

  • Molecular Diagnostics
  • Pathology
  • Pharmaceutical
  • Renal Disease
  • Therapy

The molecules developed by companies in Phase III, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Renal Disease
  • Therapy
  • United States
  • Product Initiative
  • ChemoCentryx, Inc.
  • POLYCYSTIC KIDNEY DISEASE - PIPELINE BY KADMON CORP LLC, H1 2018
  • POLYCYSTIC KIDNEY DISEASE - PIPELINE BY IC-MEDTECH INC, H1 2018

Kadmon offers products in the therapeutic areas of oncology, infectious diseases, immunology, and neurodegenerative disease.

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative

IT ALSO FOCUS IN OTHER APPLICATIONS LIKE ONCOLOGY, UROLOGY, CARDIOLOGY, INFECTIOUS DISEASE, IMMUNOLOGY AND DERMATOLOGY.

  • Renal Disease
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

The company offers services in the areas of cell biology, immunology and medicinal chemistry.

  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative
  • Angion Biomedica Corp.
  • POLYCYSTIC KIDNEY DISEASE - PIPELINE BY IPSEN SA, H2 2018
  • POLYCYSTIC KIDNEY DISEASE - PIPELINE BY KADMON CORP LLC, H2 2018

Kadmon offers products in the therapeutic areas of oncology, infectious diseases, immunology, and neurodegenerative disease.

  • Renal Disease
  • Therapy
  • United States
  • Company Operations
  • Product Initiative
  • Renal Diseases, Global, Overall
  • 4.1 Disease Overview

The Journal of Immunology; ##(##): ##-## Sato W, et al. (2005).

  • Chronic Disease
  • Pathology
  • Renal Disease
  • Deals & Alliance
  • Galectin Therapeutics Inc.

The company offers services in the areas of cell biology, immunology and medicinal chemistry.

  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative
  • Quark
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by Novartis AG, H1 2017
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017

It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas.

  • Pharmaceutical
  • Renal Disease
  • United States
  • World
  • CTI BioPharma Corp.
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY APCETH BIOPHARMA GMBH
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY F. HOFFMANN-LA ROCHE LTD

It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas.

  • Chronic Disease
  • Genitourinary System Disease
  • Pharmaceutical
  • Renal Disease
  • Product Initiative
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY APCETH BIOPHARMA GMBH, H1 2017
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY F. HOFFMANN-LA ROCHE LTD, H1 2017

It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas.

  • Chronic Disease
  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative